Frontiers in Pharmacology (Oct 2022)

EZH2: Its regulation and roles in immune disturbance of SLE

  • Yiying Yang,
  • Yiying Yang,
  • Yiying Yang,
  • Ke Liu,
  • Ke Liu,
  • Meidong Liu,
  • Meidong Liu,
  • Huali Zhang,
  • Huali Zhang,
  • Huali Zhang,
  • Muyao Guo,
  • Muyao Guo,
  • Muyao Guo

DOI
https://doi.org/10.3389/fphar.2022.1002741
Journal volume & issue
Vol. 13

Abstract

Read online

The pathogenesis of systemic lupus erythematosus (SLE) is related to immune homeostasis imbalance. Epigenetic mechanisms have played a significant role in breaking immune tolerance. Enhancer of zeste homolog 2 (EZH2), the specific methylation transferase of lysine at position 27 of histone 3, is currently found to participate in the pathogenesis of SLE through affecting multiple components of the immune system. This review mainly expounds the mechanisms underlying EZH2-mediated disruption of immune homeostasis in SLE patients, hoping to provide new ideas in the pathogenesis of SLE and new targets for future treatment.

Keywords